Guselkumab for treating moderate to severe plaque psoriasis

Equality Impact Assessment (Guidance development) (PDF 242 KB)

Final appraisal determination

Final appraisal determination document (PDF 315 KB)

Committee papers (PDF 8.44 MB)

Public committee slides (PDF 566 KB)

Final scope (PDF 89 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 169 KB)

Equality impact assessment (Scoping) (PDF 86 KB)

Final matrix (PDF 256 KB)